Morgan Stanley
TSVT

Morgan Stanley’s 2seventy bio TSVT Stock Holding History

Morgan Stanley’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,967,078
Closed -$14.7M – 8278
2025
Q1 		$14.7M Buy
2,967,078
+49,194
+2% +$156K ﹤0.01% 2999
2024
Q4 		$8.58M Buy
2,917,884
+25,774
+0.9% +$106K ﹤0.01% 3528
2024
Q3 		$13.7M Sell
2,892,110
-378,784
-12% -$1.71M ﹤0.01% 3170
2024
Q2 		$12.6M Sell
3,270,894
-1,086,612
-25% -$4.9M ﹤0.01% 3138
2024
Q1 		$23.3M Sell
4,357,506
-5,328,114
-55% -$25.1M ﹤0.01% 2530
2023
Q4 		$41.4M Buy
9,685,620
+8,332,304
+616% +$25.6M ﹤0.01% 2653
2023
Q3 		$5.3M Buy
1,353,316
+576,195
+74% +$3.78M ﹤0.01% 3693
2023
Q2 		$7.86M Sell
777,121
-388,205
-33% -$4.11M ﹤0.01% 3400
2023
Q1 		$11.9M Buy
1,165,326
+952,227
+447% +$10.9M ﹤0.01% 2980
2022
Q4 		$2M Buy
213,099
+154,808
+266% +$2.18M ﹤0.01% 4467
2022
Q3 		$849K Sell
58,291
-152,430
-72% -$2.26M ﹤0.01% 4972
2022
Q2 		$2.78M Sell
210,721
-187,683
-47% -$2.56M ﹤0.01% 4284
2022
Q1 		$6.8M Buy
398,404
+282,046
+242% +$4.78M ﹤0.01% 3348
2021
Q4 		$2.98M Buy
+116,358
New +$3.63M ﹤0.01% 4242

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Morgan Stanley's TSVT Position: Q2 2025 in Review

Morgan Stanley sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 2,967,078 shares — an estimated $14.7M sold.

Morgan Stanley first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $41.4M in Q4 2023. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Morgan Stanley reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Morgan Stanley sold 2,967,078 2seventy bio shares in Q2 2025, an estimated $14.7M.
  • Morgan Stanley first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Morgan Stanley's 2seventy bio position peaked at $41.4M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.